Cardiology
RSSArticles
-
Internal Medicine Alert - Full June 29, 2011 Issue in PDF
-
Proton Pump Inhibitors and Clopidogrel
Proton pump inhibitor use in clopidogrel-treated post-percutaneous coronary intervention patients was not associated with an increased risk of all-cause death, nonfatal myocardial infarction, repeat revascularization, or major adverse cardiovascular events. -
Clinical Briefs by Louis Kuritzky, MD
-
Telaprevir Film-Coated Tablets (Incivek™)
A second NS3/4A protease inhibitor has been approved by the FDA for the treatment of chronic hepatitis C (HCV) genotype 1, joining the recently approved boceprevir (Victrelis). Telaprevir is marketed by Vertex Pharmaceuticals as Incivek. -
Desperate Diseases Call for Drastic Diets
A very low energy diet followed by a weight maintenance program results in significant improvements in weight, obstructive sleep apnea, metabolic factors, and quality for at least a year. -
I Can't Get No Salivation
Elders who ate sorbet before a meal ate more of the rest of their meal. -
Critical Care Alert July 2011 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Abstract & Commentary: Sleep Apnea and Perioperative Complications After Noncardiac Surgery
In this study of a large administrative database, the incidence of selected complications in patients diagnosed with sleep apnea (SA) was compared to that in patients undergoing similar surgical procedures who were not diagnosed with SA. -
Abstract & Commentary: Supplemental Oxygen Administration in the Morbidly Obese: When Less is Better
Current guidelines for the use of emergency oxygen recommend its judicious use in patients with obesity-associated hypoventilation (OAH) in order to avoid worsening hypercarbia, but these guidelines have largely been based on anecdotal clinical experience rather than systematically collected evidence.